Rituximab retherapy in aggressive non Hodgkin lymphoma after inital immunochemotherapeutic treatment with rituximab

被引:0
|
作者
Borgerding, A. [1 ]
Hasenkamp, J. [1 ]
Truemper, L. [1 ]
Glass, B. [2 ]
机构
[1] Univ Hosp, Gottingen, Germany
[2] Asklepios Klin St Georg, Dept Hematol, Hamburg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:220 / 221
页数:2
相关论文
共 50 条
  • [21] Treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma with a combination of a taxane, cyclophosphamide and rituximab.
    Krämer, A
    Zoz, M
    Krasniqi, F
    Görner, M
    Leo, E
    Ho, AD
    BLOOD, 2001, 98 (11) : 135A - 135A
  • [22] Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia
    Fredrick Hagemeister
    Drugs, 2010, 70 : 261 - 272
  • [23] Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia
    Hagemeister, Fredrick
    DRUGS, 2010, 70 (03) : 261 - 272
  • [24] Systemic lupus erythematosus following rituximab treatment for non-Hodgkin lymphoma
    Soura, Efthymia
    Avgerinou, Georgia
    Papoutsaki, Marina
    Stavropoulos, Panagiotis
    Antoniou, Christina
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (03): : 298 - 301
  • [25] PROLONGATION OF THE TREATMENT OF MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH INDOLENT NON HODGKIN B LYMPHOMA
    Nunez Garcia, A.
    Sevil Puras, F. J.
    Aguilar Franco, C.
    Faura Petisco, M., V
    HAEMATOLOGICA, 2015, 100 : 267 - 268
  • [26] Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma
    Fernandez-Canabate, Eva
    Fernandez-Canabate, Sonia
    FARMACIA HOSPITALARIA, 2018, 42 (01) : 20 - 21
  • [27] Aggressive craniofacial lymphoma in the pre-rituximab and rituximab era
    Murawski, N.
    Zwick, C.
    Glass, B.
    Zeynalova, S.
    Fleckenstein, J.
    Ruebe, C.
    Ziepert, M.
    Kempf, B.
    Poeschel, V
    Loeffler, M.
    Schmitz, N.
    Pfreundschuh, M.
    ONKOLOGIE, 2010, 33 : 203 - 204
  • [28] Combination of plitidepsin and rituximab is effective for treatment of rituximab resistant Non-Hodgkin's B-cell lymphoma
    Barboza, Nora
    Medina, Daniel
    Budak, Tulin
    Aracil, Miguel
    Paz, Me
    Bertino, Joseph
    Banerjee, Debabrata
    CANCER RESEARCH, 2009, 69
  • [29] Efficacy and safety of Rituximab plus CHOP in IR and maintenance therapy with rituximab vs observation in De novo Aggressive Non-Hodgkin Lymphoma
    Tripp, Francisco
    Baez, Enrique
    Avila, Elsa
    Baltazar, Severiano
    Garces, Oscar
    Reyes, Gustavo
    Batista, Benjamin
    Zaragoza, Alva
    Vela-Ojeda, Jorge
    Villela, Luis
    BLOOD, 2007, 110 (11) : 193B - 194B
  • [30] Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma
    Coiffier, B
    TUMORI, 2002, 88 (01) : S26 - S28